Device type · DQO
Catheter, Intravascular, Diagnostic
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DQO
Cardiovascular
Device class
Class II
FDA decisions since 2015
61
510(k), De Novo and PMA
Adverse event reports
913
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Catheter, Intravascular, Diagnostic
- Product code
- DQO
- Device class
- Class II
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1200
- Specialty
- Cardiology, Interventional Cardiology
- FDA record
- Classification database entry for DQO
Latest FDA decisions
The 8 newest of 61 since 2015.
K261455 · Decided Jun 26, 2026 · 56 days after receipt
Device type: Catheter, Intravascular, Diagnostic (DQO) · Cardiology
Bioptimal International Pte. , Ltd.
K252702 · Decided May 28, 2026 · 274 days after receipt
Device type: Catheter, Intravascular, Diagnostic (DQO) · Cardiology
K254278 · Decided Mar 25, 2026 · 85 days after receipt
Device type: Catheter, Intravascular, Diagnostic (DQO) · Cardiology
58 more FDA decisions with a free account
Reports received
913
Received Nov 1, 2025 to Nov 19, 2026. Includes 14 of another or unstated type.
Malfunction reports
797
87% of reports
Injury reports
99
11% of reports
Death reports
3
0.3% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 29 | 10 | 0 | 0 |
| Jan 24 | 28 | 14 | 0 | 0 |
| Feb 24 | 27 | 16 | 3 | 0 |
| Mar 24 | 16 | 10 | 0 | 0 |
| Apr 24 | 24 | 7 | 0 | 1 |
| May 24 | 32 | 11 | 0 | 0 |
| Jun 24 | 23 | 11 | 1 | 0 |
| Jul 24 | 30 | 25 | 1 | 0 |
| Aug 24 | 29 | 10 | 1 | 0 |
| Sep 24 | 30 | 14 | 0 | 0 |
| Oct 24 | 23 | 12 | 0 | 0 |
| Nov 24 | 26 | 14 | 0 | 0 |
| Dec 24 | 45 | 27 | 0 | 0 |
| Jan 25 | 26 | 9 | 0 | 0 |
| Feb 25 | 29 | 12 | 1 | 0 |
| Mar 25 | 47 | 10 | 1 | 0 |
| Apr 25 | 21 | 22 | 0 | 0 |
| May 25 | 46 | 19 | 0 | 0 |
| Jun 25 | 36 | 15 | 0 | 0 |
| Jul 25 | 56 | 9 | 1 | 0 |
| Aug 25 | 35 | 16 | 0 | 0 |
| Sep 25 | 45 | 2 | 2 | 2 |
| Oct 25 | 62 | 6 | 0 | 0 |
| Nov 25 | 81 | 7 | 0 | 0 |
| Dec 25 | 28 | 19 | 0 | 0 |
| Jan 26 | 97 | 4 | 1 | 0 |
| Feb 26 | 37 | 6 | 0 | 0 |
| Mar 26 | 62 | 4 | 0 | 0 |
| Apr 26 | 40 | 6 | 1 | 0 |
| May 26 | 97 | 9 | 0 | 0 |
| Jun 26 | 74 | 7 | 0 | 0 |
| Jul 26 | 67 | 9 | 0 | 0 |
| Aug 26 | 63 | 4 | 1 | 0 |
| Sep 26 | 73 | 8 | 0 | 6 |
| Oct 26 | 78 | 16 | 0 | 8 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
7 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Detachment of Device or Device Component184
- Degraded120
- Crack72
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions764
- Foreign Body In Patient71
- Insufficient Information36
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-3214-2026 · Started Aug 24, 2026 · Posted by FDA Sep 23, 2026
Reason given: Tip may fracture or detach, leading to device fragments remaining within the patient or migrating through the vasculature. Patient impact may include prolonged procedure or life-threatening embolism.
Cause as FDA categorized it: Process control
Z-1934-2026 · Started Apr 2, 2026 · Posted by FDA May 1, 2026
Reason given: Marker bands may be at an increased risk of cracking/breakage. Potential adverse events that may result include increased procedural time, harms associated with device fragmentation/separation, and vessel injury. In a worst-case scenario, device fragmentation and separation may cause life-threatening harm or death.
Cause as FDA categorized it: Under Investigation by firm
Z-1935-2026 · Started Apr 2, 2026 · Posted by FDA May 1, 2026
Reason given: Marker bands may be at an increased risk of cracking/breakage. Potential adverse events that may result include increased procedural time, harms associated with device fragmentation/separation, and vessel injury. In a worst-case scenario, device fragmentation and separation may cause life-threatening harm or death.
Cause as FDA categorized it: Under Investigation by firm
282 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.